Cytek Biosciences (CTKB) Change in Receivables (2020 - 2026)
Cytek Biosciences (CTKB) posted Change in Receivables of -$9.6 million for Q1 2026, down 256.93% on a QoQ basis from $6.1 million in Q4 2025, and down 49.56% year-over-year from -$19.1 million in Q1 2025.
Cytek Biosciences (CTKB) Change in Receivables (2020 - 2026) Analysis & Trends
Cytek Biosciences' Change in Receivables history runs 7 years deep, the most recent figure standing at -$9.6 million for Q1 2026.
- Quarterly Change in Receivables fell 49.56% year-over-year to -$9.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.6 million (down 210.89% YoY) and the FY2025 annual result came in at -$368000.0, down 106.78% from the prior year.
- Change in Receivables was -$9.6 million for Q1 2026 at Cytek Biosciences, down from $6.1 million in the prior quarter.
- Across five years, Change in Receivables topped out at $9.3 million in Q4 2024 and bottomed at -$9.6 million in Q1 2026.
- A 5-year average of $1.3 million and a median of $1.0 million in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2023 — Change in Receivables slumped 683.33% — and 2024, when it jumped 3647.15%.
- Cytek Biosciences' Change in Receivables stood at $8.0 million in 2022, then slumped by 103.3% to -$263000.0 in 2023, then soared by 3647.15% to $9.3 million in 2024, then sank by 34.12% to $6.1 million in 2025, then slumped by 256.93% to -$9.6 million in 2026.
- Business Quant data shows CTKB's Change in Receivables at -$9.6 million in Q1 2026, $6.1 million in Q4 2025, and $587000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn | -9.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.65 Mn |
| Mar 31, 2026 | -9.65 Mn |
| Dec 31, 2025 | 6.15 Mn |
| Dec 31, 2025 | 6.15 Mn |
| Sep 30, 2025 | 587,000.00 |
| Sep 30, 2025 | 587,000.00 |
| Jun 30, 2025 | -652,000.00 |
| Jun 30, 2025 | -652,000.00 |
| Mar 31, 2025 | -6.45 Mn |
| Mar 31, 2025 | -6.45 Mn |
| Dec 31, 2024 | 9.33 Mn |
| Dec 31, 2024 | 9.33 Mn |
| Sep 30, 2024 | 6.25 Mn |
| Sep 30, 2024 | 6.25 Mn |
| Jun 30, 2024 | -5.92 Mn |
| Jun 30, 2024 | -5.92 Mn |
| Mar 31, 2024 | -4.24 Mn |
| Mar 31, 2024 | -4.24 Mn |
| Dec 31, 2023 | -263,000.00 |
| Dec 31, 2023 | -263,000.00 |